Table 2: Levels of Matrix Metalloproteinase-1 (MMP-1), Matrix Metalloproteinase-9 (MMP-9), Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) and Interleukin-6 (IL-6) in Different Clinical Groups
| Marker |
Clinic |
N |
Mean |
Minimum |
Maximum |
|
| MMP-1 (ng/ml) |
control |
30 |
0.989 |
0.10 |
4.08 |
|
STEMI |
25 |
5.8232 |
0.08 |
13.60 |
|
NSTEMI |
16 |
4.6969 |
0.21 |
9.89 |
|
USAP |
29 |
2.3224 |
0.28 |
11.87 |
|
SAP |
34 |
2.8668 |
0.11 |
14.73 |
|
Total |
134 |
3.0987 |
0.08 |
14.73 |
|
| MMP-9 |
control |
30 |
175.16 |
52.0 |
431.0 |
| (ng/ml) |
STEMI |
25 |
454.36 |
58.0 |
1500.0 |
|
NSTEMI |
16 |
284.43 |
52.0 |
1008.0 |
|
USAP |
29 |
209.93 |
31.0 |
537.0 |
|
SAP |
34 |
291.67 |
52.0 |
1261.0 |
|
Total |
134 |
277.38 |
31.0 |
1500.0 |
|
| IL-6 |
control |
30 |
1.81 |
1.55 |
2.88 |
| (pg/ml) |
STEMI |
25 |
2.74 |
1.55 |
6.06 |
|
NSTEMI |
16 |
2.96 |
1.64 |
6.93 |
|
USAP |
29 |
2.19 |
1.55 |
6.86 |
|
SAP |
34 |
2.13 |
1.55 |
7.01 |
|
Total |
134 |
2.28 |
1.55 |
7.01 |
|
| TIMP-1 |
control |
30 |
527.79 |
177.20 |
953.00 |
| (ng/ml) |
STEMI |
25 |
466.68 |
65.20 |
768.50 |
|
NSTEMI |
16 |
478.88 |
44.0 |
720.70 |
|
USAP |
29 |
516.69 |
110.5 |
1212.80 |
|
SAP |
34 |
551.69 |
111.10 |
1280.00 |
|
Total |
134 |
514.21 |
44.0 |
1280.00 |